$SHPG Receives Approval of FIRAZYR® for the Treatment of Hereditary Angioedema (HAE) Attacks in Japan

05:32 EDT 21 Sep 2018 | Odi Bruckman

$SHPG Receives Approval of FIRAZYR® for the Treatment of Hereditary Angioedema (HAE) Attacks in Japan

More From BioPortfolio on "$SHPG Receives Approval of FIRAZYR® for the Treatment of Hereditary Angioedema (HAE) Attacks in Japan"